Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000006

CHIEF FINANCIAL OFFICER acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Andrade Robert CHIEF FINANCIAL OFFICER 2026-01-15 Option exercise +10,000 $2.45 $24,500 201,100 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Andrade Robert CHIEF FINANCIAL OFFICER 2026-01-15 Option exercise · Stock Options −10,000 $2.45 $24,500 826,567 D: show line 2 in the form
Loading xslF345X05/form4-01152026_040101.xml…